sufferers ought to be notified of any stem cell procedure involving minimally manipulated cells not approved or accredited with the FDA. This could significantly improve the means for men and women to safely access hematopoietic stem cell transplants, which provide the possible for any treatment or extended disease-cost-free survival to individual